Bivalent respiratory syncytial virus mRNA vaccine(Ruiji Biotech/Ruiji Biological)

二价呼吸道合胞病毒mRNA疫苗（瑞佶生物/瑞吉生物）

Report date: 2025/03/11 15:41:40

Base Information

Drug NameBivalent respiratory syncytial virus mRNA vaccine(Ruiji Biotech/Ruiji Biological)
Drug Alias NameN/A
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsRespiratory Syncytial Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesWuhan Ruiji Biotechnology Co LtdShenzhen Ruiji Biological Technology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesShenzhen Ruiji Biological Technology Co LtdWuhan Ruiji Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsRespiratory Syncytial Virus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A